SPRO (Spero Therapeutics, Inc. Common Stock) Stock Analysis - Community
Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of May 21, 2026, SPRO trades at $2.64 with a market cap of $149.39M and a P/E ratio of 0.00. SPRO moved +1.16% today. Year to date, SPRO is +8.23%; over the trailing twelve months it is +286.65%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade SPRO?
Rallies community data for SPRO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Rajavelu Esther sold 25.24K (~$63.35K) on May 4, 2026.
Rajavelu Esther sold 37.10K (~$87.56K) on Feb 6, 2026.
Rajavelu Esther sold 50.82K (~$119.93K) on Feb 6, 2026.
SPRO Analyst Consensus
SPRO analyst coverage data. Average price target: $0.00.
Common questions about SPRO
How does the Rallies community trade SPRO?
Rallies community data for SPRO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for SPRO?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for SPRO when enough community data is available.
Is SPRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SPRO. It does not provide personalized investment advice.